A detailed history of Holderness Investments CO transactions in Abbott Laboratories stock. As of the latest transaction made, Holderness Investments CO holds 6,111 shares of ABT stock, worth $716,575. This represents 0.15% of its overall portfolio holdings.

Number of Shares
6,111
Previous 6,169 0.94%
Holding current value
$716,575
Previous $641,000 8.58%
% of portfolio
0.15%
Previous 0.15%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$100.07 - $118.13 $5,804 - $6,851
-58 Reduced 0.94%
6,111 $696,000
Q2 2024

Aug 13, 2024

SELL
$100.73 - $112.44 $4,532 - $5,059
-45 Reduced 0.72%
6,169 $641,000
Q1 2024

May 13, 2024

BUY
$109.52 - $120.96 $13,251 - $14,636
121 Added 1.99%
6,214 $706,000
Q4 2023

Feb 13, 2024

BUY
$90.19 - $110.4 $180 - $220
2 Added 0.03%
6,093 $670,000
Q3 2023

Nov 15, 2023

BUY
$95.53 - $114.62 $191 - $229
2 Added 0.03%
6,091 $589,000
Q2 2023

Aug 15, 2023

BUY
$100.78 - $112.29 $13,806 - $15,383
137 Added 2.3%
6,089 $663,000
Q1 2023

May 12, 2023

BUY
$96.86 - $114.01 $3,874 - $4,560
40 Added 0.68%
5,952 $602,000
Q4 2022

Feb 13, 2023

SELL
$95.06 - $111.52 $14,639 - $17,174
-154 Reduced 2.54%
5,912 $649,000
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $23,986 - $28,991
-235 Reduced 3.73%
6,066 $659,000
Q1 2022

May 12, 2022

SELL
$114.02 - $139.04 $41,389 - $50,471
-363 Reduced 5.45%
6,301 $746,000
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $301,099 - $333,103
-2,581 Reduced 27.92%
6,664 $787,000
Q1 2021

May 11, 2021

SELL
$108.84 - $128.23 $43,536 - $51,291
-400 Reduced 4.15%
9,245 $1.11 Million
Q4 2020

Feb 05, 2021

SELL
$105.0 - $114.42 $17,220 - $18,764
-164 Reduced 1.67%
9,645 $1.06 Million
Q2 2020

Aug 13, 2020

BUY
$76.57 - $98.0 $14,854 - $19,012
194 Added 2.02%
9,809 $897,000
Q1 2020

May 13, 2020

SELL
$62.82 - $91.86 $32,917 - $48,134
-524 Reduced 5.17%
9,615 $759,000
Q4 2019

Feb 05, 2020

SELL
$78.51 - $87.4 $10,991 - $12,236
-140 Reduced 1.36%
10,139 $881,000
Q3 2019

Nov 01, 2019

SELL
$81.84 - $88.74 $1,964 - $2,129
-24 Reduced 0.23%
10,279 $860,000
Q2 2019

Aug 02, 2019

SELL
$72.88 - $85.0 $14,576 - $17,000
-200 Reduced 1.9%
10,303 $866,000
Q1 2019

May 20, 2019

SELL
$66.22 - $80.06 $2,582 - $3,122
-39 Reduced 0.37%
10,503 $840,000
Q4 2018

Feb 13, 2019

SELL
$65.56 - $74.27 $30,288 - $34,312
-462 Reduced 4.2%
10,542 $763,000
Q3 2018

Nov 13, 2018

SELL
$60.81 - $73.36 $1,824 - $2,200
-30 Reduced 0.27%
11,004 $807,000
Q1 2018

May 10, 2018

BUY
$56.27 - $63.62 $618 - $699
11 Added 0.1%
11,034 $661,000
Q4 2017

Feb 13, 2018

SELL
$53.68 - $57.47 $1,878 - $2,011
-35 Reduced 0.32%
11,023 $629,000
Q3 2017

Nov 09, 2017

BUY
$48.06 - $53.64 $531,447 - $593,151
11,058
11,058 $590,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Holderness Investments CO Portfolio

Follow Holderness Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holderness Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Holderness Investments CO with notifications on news.